US Patent Issued to The Johns Hopkins University on July 15 for "Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion proteins and uses thereof" (Maryland Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,673, issued on July 15, was assigned to The Johns Hopkins University.

"Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion proteins and uses thereof" was invented by T. C. Wu (Stevenson, Md.), Chien-Fu Hung (Timonium, Md.) and Brandon Lam (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel fusion protein of Flt3L and albumin and its use to increase the Flt3L half-life in vivo and to deliver Flt3L to immune cells in a subject to enhance alternative dendritic cell populations. Use of the fusion protein in combination with other chemotherapeutic, radiotherapeutic and immunotherapeutic me...